Glenmark Pharma Q3 Results Review— Regulatory Compliance Critical For Turnaround In U.S. Says ICICI Securities

NDTV Profit

Factuality

Ownership

Glenmark Pharma Q3 Results Review— Regulatory Compliance Critical For Turnaround In U.S. Says ICICI Securities

Revival in US hinges on its ability to adhere with regulatory standards and timely approval of gFlovent and other assets. India biz revenue run-rate slowed down in Q3 FY25 and Glenmark's management now anticipates sales from India to grow at 9-10%.NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer ND…